Antagonistic expression of hepatitis C virus and alpha interferon in lymphoid cells during persistent occult infection

Journal of Viral Hepatitis

Volumn 14, Issue 8, 2007, Pages 537-548

  Pham, T N Q ^a   Mulrooney Cousins, P M ^a   Mercer, S E ^a   MacParland, S A ^a   Inglot, M ^b   Zalewska, M ^b   Simon, K ^b   Michalak, T I ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Hepatitis C virus lymphotropism; Hepatitis C virus persistence; Interferon alpha; Monocytes; Occult hepatitis C virus infection; T and B lymphocytes

Indexed keywords

ALPHA INTERFERON; LIVER ENZYME; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON; RIBAVIRIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERFERON INDUCTION; LIVER FUNCTION TEST; LYMPHOCYTE; LYMPHOID CELL; MALE; MONOCYTE; NUCLEIC ACID AMPLIFICATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; UPREGULATION; VIRUS DETECTION; VIRUS EXPRESSION; VIRUS GENOME; VIRUS INHIBITION; VIRUS LOAD; VIRUS REPLICATION;

ADULT; BASE SEQUENCE; DNA, VIRAL; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MALE; MOLECULAR SEQUENCE DATA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE ALIGNMENT; VIRAL LOAD; VIRUS REPLICATION;

EID: 34447569173     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2006.00834.x     Document Type: Article

References (45)

1. Seeff LB. Natural history of chronic hepatitis C. Hepatology 2002 36 : S35 S46.
2. Morsica G, Tambussi G, Sitia R et al. Replication of hepatitis C virus in B lymphocytes (CD19+). Blood 1999 94 : 1138 1139.
3. Laskus T, Radkowski M, Piasek A et al. Hepatitis C virus in lymphoid cells of patients coinfected with human immunodeficiency virus type 1: evidence of active replication in monocytes/macrophages and lymphocytes. J Infect Dis 2000 181 : 442 448.
4. Goutagny N, Fatmi A, De L et al. Evidence of viral replication in circulating dendritic cells during hepatitis C virus infection. J Infect Dis 2003 187 : 1951.
5. Pham TNQ, MacParland SA, Coffin CS, Lee SS, Bursey FR, Michalak TI. Mitogen-induced upregulation of hepatitis C virus expression in human lymphoid cells. J Gen Virol 2005 86 : 657 666.
6. Pham TNQ, MacParland SA, Mulrooney PM, Cooksley H, Naoumov NV, Michalak TI. Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C. J Virol 2004 78 : 5867 5874.
7. Lee WM, Polson JE, Carney DS, Sahin B, Gale Jr. M. Re-emergence of hepatitis C virus after 8.5 years in a patient with hypogammaglobulinemia: evidence for an occult viral reservoir. J Infect Dis 2005 192 : 1088 1092.
8. Carreno V, Pardo M, Lopez-Alcorocho JM, Rodriguez-Inigo E, Bartolome J, Castillo I. Detection of hepatitis C virus (HCV) RNA in the liver of healthy, anti-HCV antibody-positive, serum HCV RNA-negative patients with normal alanine aminotransferase levels. J Infect Dis 2006 194 : 53 60.
9. Radkowski M, Wilkinson J, Nowicki M et al. Search for hepatitis C virus negative strand RNA sequences and analysis of viral sequence in the central nervous system: evidence of replication. J Virol 2002 76 : 600 608.
10. Forton DM, Karayianis P, Mahmud N, Taylor-Robinson SD, Thomas HC. Identification of unique hepatitis C virus quasispecies in the central nervous system and comparative analysis of internal translational efficiency of brain, liver and serum variants. J Virol 2004 78 : 5170 5183.
11. Castillo I, Pardo M, Bartolome J et al. Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown. J Infect Dis 2004 189 : 7 14.
12. Castillo I, Rodriguez-Inigo E, Bartolome J et al. Hepatitis C virus replicates in peripheral blood mononuclear cells in patients with occult hepatitis C virus infection. Gut 2005 54 : 682 685.
13. Shimizu YK, Iwamoto A, Hijikata M, Purcell RH, Yoshikura H. Evidence for in vitro replication of hepatitis C virus genome in a human T cell line. Proc Natl Acad Sci USA 1992 89 : 5477 5481.
14. Sung VM, Shimodaira S, Doughty AL et al. Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection. J Virol 2003 77 : 2134 2146.
15. Radkowski M., Bednarska A, Horban A et al. Infection of primary human macrophages with hepatitis C virus in vitro: induction of tumor necrosis factor-alpha and interleukin 8. J Gen Virol 2004 85 : 47 59.
16. MacParland SA, Pham TNQ, Gujar SA, Michalak TI. De novo infection and propagation of wild-type hepatitis C virus in human T lymphocytes in vitro. J Gen Virol 2006 87 : 3577 3586.
17. Oldstone MB. How viruses escape from cytotoxic T lymphocytes: molecular parameters and players. Virology 1997 234 : 179 185.
18. Michalak TI. Occult persistence and lymphotropism of hepadnaviral infection: insights from the woodchuck viral hepatitis model. Immunol Rev 2000 174 : 98 111.
19. Feld JJ, Hoofnagle JH. Mechanism of action of interferon and ribavirin in treatment of hepatitis C. Nature 2005 436 : 967 972.
20. Pawlotsky JM. Use and interpretation of virological tests for hepatitis C. Hepatology 2002 36 : 0S65 S73.
21. Radkowski M, Gallegos-Orozco JF, Jablonska J et al. Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C. Hepatology 2005 41 : 106 114.
22. Carreno V, Castillo I, Rodriguez-Inigo E et al. Hepatitis C virus persists and replicates in the liver of the majority of sustained responder patients to antiviral treatment. Hepatology 2005 42 : 284A.
23. Pham TNQ, Michalak TI. Occult hepatitis C virus persistence: identification and characteristics. Med Lab Obser 2006 38 : 20 22.
24. Coffin CS, Pham TNQ, Urbanski SJ, Michalak TI, Lee SS. Persistent hepatic alterations in individuals with occult HCV infection following sustained virological response to antiviral therapy. J Hepatol 2006 44 : S196.
25. Triantafilou M, Triantafilou K. Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. Trends Immunol 2002 23 : 301 304.
26. Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994 22 : 4673 4680.
27. Kato N, Hijikata M, Ootsuyama Y et al. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci USA 1990 87 : 9524 9528.
28. Samuel CE. Antiviral actions of interferons: interferon-regulated cellular proteins and their surprisingly selective antiviral activities. Virology 1991 183 : 1 11.
29. Laskus T, Radkowski M, Wilkinson J, Vargas H, Rakela J. The origin of hepatitis C virus reinfecting transplanted livers: serum-derived versus peripheral blood mononuclear cell-derived virus. J Infect Dis 2002 185 : 417 421.
30. Nakajima N, Hijikata M, Yoshikura H, Shimizu YK. Characterization of long-term cultures of hepatitis C virus. J Virol 1996 70 : 3325 3329.
31. Maggi F, Fornai C, Vatteroni ML et al. Differences in hepatitis C virus quasispecies composition between liver, peripheral blood mononuclear cells and plasma. J Gen Virol 1997 78 : 1521 1525.
32. Navas S, Martin J, Quiroga JA, Castillo I, Carreno V. Genetic diversity and tissue compartmentalization of the hepatitis C virus genome in blood mononuclear cells, liver, and serum from chronic hepatitis C patients. J Virol 1998 72 : 1640 1646.
33. Roque-Afonso AM, Ducoulombier D, Di Liberto G et al. Compartmentalization of hepatitis C virus genotypes between plasma and peripheral blood mononuclear cells. J Virol 2005 79 : 6349 6357.
34. Mogensen SC. Role of macrophages in natural resistance to virus infections. Microbiol Rev 1979 43 : 1 26.
35. Chen YC, Wang SY. Activation of terminally differentiation monocytes/macrophages by dengue virus: productive infection, hierarchical production of innate cytokines and chemokines, and the synergistic effects of lipopolysaccharide. J Virol 2002 76 : 9877 9887.
36. Dewerchin HL, Cornelissen E, Nauwynck HJ. Replication of feline coronaviruses in peripheral blood monocytes. Arch Virol 2005 150 : 2483 2500.
37. Perno CF, Yarchoan R, Cooney DA et al. Replication of human immunodeficiency virus in monocytes. Granulocyte/macrophage colony-stimulating factor (GM-CSF) potentiates viral production yet enhances the antiviral effect mediated by 3′-azido-2′3′-dideoxythymidine (AZT) and other dideoxynucleoside congeners of thymidine. J Exp Med 1989 169 : 933 951.
38. Mulrooney PM, Michalak TI. Quantitative detection of hepadnavirus- infected lymphoid cells by in situ PCR combined with flow cytometry: implications for the study of occult virus persistence. J Virol 2003 77 : 970 979.
39. Larrea E, Alberdi A, Castelruiz Y, Boya P, Civeira M-P, Prieto J. Expression of interferon- subtypes in peripheral blood mononuclear cells from patients with chronic hepatitis C: a role for interferon-5. J Viral Hep 2001 8 : 103 110.
40. Castelruiz Y, Larrea E, Boya P, Civeira MP, Prieto J. Interferon alpha subtypes and levels of type I interferons in the liver and peripheral mononuclear cells in patients with chronic hepatitis C and controls. Hepatology 1999 29 : 1900 1904.
41. Monini P, Carlini F, Sturzl M et al. Alpha interferon inhibits human herpesvirus-8 (HHV) reactivation in primary effusion lymphoma cells and reduces HHV-8 load in cultured peripheral blood mononuclear cells. J Virol 1999 73 : 4029 4041.
42. Kurane I, Ennis FA. Production of interferon alpha by dengue virus-infected human monocytes. J Gen Virol 1988 69 : 445 449.
43. Samuel MA, Diamond MS. Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival. J Virol 2005 79 : 13350 13361.
44. Duan XZ, Wang M, Li HW, Zhuang H, Xu D, Wang FS. Decreased frequency and function of circulating plasmacytoid dendritic cells (pDC) in hepatitis B virus infected humans. J Clin Immunol 2004 24 : 637 646.
45. Jiang W, Lederman MM, Salkowitz JR, Rodriguez B, Harding CV, Sieg SF. Impaired monocyte maturation in response CpG oligodeoxynucleotide is related to viral RNA levels in human immunodeficiency virus disease and is at least partially mediated by deficiencies in alpha/beta interferon responsiveness and production. J Virol 2005 79 : 4109 4119.